TipRanks
Cigna Corp (CH:CGN)
:CGN
Switzerland Market
CGN
Cigna
RESEARCH TOOLSreports

Cigna (CGN) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

CGN Analyst Ratings

Moderate Buy
19Ratings
Moderate Buy
13 Buy
6 Hold
0 Sell
Based on 19 analysts giving stock ratings to
Cigna
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CGN Stock 12 Month Forecast

Average Price Target

―
Based on 19 Wall Street analysts offering 12 month price targets for Cigna in the last 3 months. The average price target is CHF282.01 with a high forecast of CHF322.05 and a low forecast of CHF241.33. The average price target represents a ― change from the last price of ―.
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
Highest Price TargetCHF322.05Average Price TargetCHF282.01Lowest Price TargetCHF241.33
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
RBC Capital Analyst forecast on CH:CGN
Ben Hendrix
RBC Capital
RBC Capital
CHF280.44
Buy
―
Reiterated
10/07/26
RBC Capital Remains a Buy on Cigna (CI)
Bernstein Analyst forecast on CH:CGN
Lance Wilkes
Bernstein
Bernstein
CHF317.05→CHF322.05
Buy
―
Reiterated
10/05/26
Bernstein Sticks to Their Buy Rating for Cigna (CI)
Truist Financial Analyst forecast on CH:CGN
David S Macdonald
Truist Financial
Truist Financial
CHF291.26
Buy
―
Reiterated
10/02/26
Analysts Offer Insights on Healthcare Companies: Cigna (NYSE: CI), Wave Life Sciences (NASDAQ: WVE) and Regeneron (NASDAQ: REGN)
Piper Sandler Analyst forecast on CH:CGN
Jessica Tassan
Piper Sandler
Piper Sandler
CHF287.93→CHF307.9
Buy
―
Reiterated
10/02/26
Cigna price target raised to $370 from $346 at Piper SandlerCigna price target raised to $370 from $346 at Piper Sandler
Leerink Partners Analyst forecast on CH:CGN
Unknown Analyst
Leerink Partners
Not Ranked
Leerink Partners
CHF249.65
Hold
―
Reiterated
10/01/26
Cigna (CI) Gets a Hold from Leerink Partners
Oppenheimer Analyst forecast on CH:CGN
Michael Wiederhorn
Oppenheimer
Oppenheimer
CHF303.74
Buy
―
Reiterated
10/01/26
Analysts Are Bullish on Top NA Stocks: Cigna (CI), Millrose Properties Inc Class A (MRP)
Evercore ISI Analyst forecast on CH:CGN
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
CHF241.33
Hold
―
Reiterated
10/01/26
Analysts Offer Insights on NA Companies: Cigna (NYSE: CI), Hartford Insurance (NYSE: HIG) and Health In Tech, Inc. Class A (NASDAQ: HIT)
Bank of America Securities Analyst forecast on CH:CGN
Kevin Fischbeck
Bank of America Securities
Bank of America Securities
CHF314.56
Buy
―
Reiterated
10/01/26
Analysts Offer Insights on NA Companies: Factset Research (NYSE: FDS), Alphabet Class A (NASDAQ: GOOGL) and Cigna (NYSE: CI)
Barclays Analyst forecast on CH:CGN
Andrew Mok CFA
Barclays
Barclays
CHF257.97
Hold
―
Reiterated
10/01/26
Barclays Sticks to Its Hold Rating for Cigna (CI)
TD Cowen Analyst forecast on CH:CGN
Charles Rhyee
TD Cowen
TD Cowen
CHF281.27
Buy
―
Reiterated
09/30/26
Wall Street Analysts Are Bullish on Top NA Picks
Wells Fargo Analyst forecast on CH:CGN
Stephen Baxter
Wells Fargo
Wells Fargo
CHF255.47
Hold
―
Reiterated
09/30/26
Analysts Offer Insights on NA Companies: Factset Research (NYSE: FDS), Cigna (NYSE: CI) and Hormel Foods (NYSE: HRL)
Morgan Stanley Analyst forecast on CH:CGN
Erin Wright
Morgan Stanley
Morgan Stanley
CHF300.41
Buy
―
Reiterated
09/29/26
Cigna: Buy Rating Reiterated as Specialty Strength Seen Offsetting PBM Headwinds; Price Target Maintained at $361
Jefferies Analyst forecast on CH:CGN
David Windley
Jefferies
Jefferies
CHF279.61→CHF255.47
Hold
―
Downgraded
08/03/26
Cigna downgraded to Hold from Buy at JefferiesCigna downgraded to Hold from Buy at Jefferies
Raymond James Analyst forecast on CH:CGN
Parker Snure
Raymond James
Raymond James
CHF291.26→CHF266.29
Buy
―
Reiterated
08/03/26
Cigna downgraded to Outperform from Strong Buy at Raymond JamesCigna downgraded to Outperform from Strong Buy at Raymond James
Goldman Sachs Analyst forecast on CH:CGN
Scott Fidel
Goldman Sachs
Goldman Sachs
CHF282.94→CHF292.92
Buy
―
Reiterated
08/02/26
Analysts Conflicted on These Healthcare Names: AbbVie (NYSE: ABBV), HealthStream (NASDAQ: HSTM) and Cigna (NYSE: CI)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
RBC Capital Analyst forecast on CH:CGN
Ben Hendrix
RBC Capital
RBC Capital
CHF280.44
Buy
―
Reiterated
10/07/26
RBC Capital Remains a Buy on Cigna (CI)
Bernstein Analyst forecast on CH:CGN
Lance Wilkes
Bernstein
Bernstein
CHF317.05→CHF322.05
Buy
―
Reiterated
10/05/26
Bernstein Sticks to Their Buy Rating for Cigna (CI)
Truist Financial Analyst forecast on CH:CGN
David S Macdonald
Truist Financial
Truist Financial
CHF291.26
Buy
―
Reiterated
10/02/26
Analysts Offer Insights on Healthcare Companies: Cigna (NYSE: CI), Wave Life Sciences (NASDAQ: WVE) and Regeneron (NASDAQ: REGN)
Piper Sandler Analyst forecast on CH:CGN
Jessica Tassan
Piper Sandler
Piper Sandler
CHF287.93→CHF307.9
Buy
―
Reiterated
10/02/26
Cigna price target raised to $370 from $346 at Piper SandlerCigna price target raised to $370 from $346 at Piper Sandler
Leerink Partners Analyst forecast on CH:CGN
Unknown Analyst
Leerink Partners
Not Ranked
Leerink Partners
CHF249.65
Hold
―
Reiterated
10/01/26
Cigna (CI) Gets a Hold from Leerink Partners
Oppenheimer Analyst forecast on CH:CGN
Michael Wiederhorn
Oppenheimer
Oppenheimer
CHF303.74
Buy
―
Reiterated
10/01/26
Analysts Are Bullish on Top NA Stocks: Cigna (CI), Millrose Properties Inc Class A (MRP)
Evercore ISI Analyst forecast on CH:CGN
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
CHF241.33
Hold
―
Reiterated
10/01/26
Analysts Offer Insights on NA Companies: Cigna (NYSE: CI), Hartford Insurance (NYSE: HIG) and Health In Tech, Inc. Class A (NASDAQ: HIT)
Bank of America Securities Analyst forecast on CH:CGN
Kevin Fischbeck
Bank of America Securities
Bank of America Securities
CHF314.56
Buy
―
Reiterated
10/01/26
Analysts Offer Insights on NA Companies: Factset Research (NYSE: FDS), Alphabet Class A (NASDAQ: GOOGL) and Cigna (NYSE: CI)
Barclays Analyst forecast on CH:CGN
Andrew Mok CFA
Barclays
Barclays
CHF257.97
Hold
―
Reiterated
10/01/26
Barclays Sticks to Its Hold Rating for Cigna (CI)
TD Cowen Analyst forecast on CH:CGN
Charles Rhyee
TD Cowen
TD Cowen
CHF281.27
Buy
―
Reiterated
09/30/26
Wall Street Analysts Are Bullish on Top NA Picks
Wells Fargo Analyst forecast on CH:CGN
Stephen Baxter
Wells Fargo
Wells Fargo
CHF255.47
Hold
―
Reiterated
09/30/26
Analysts Offer Insights on NA Companies: Factset Research (NYSE: FDS), Cigna (NYSE: CI) and Hormel Foods (NYSE: HRL)
Morgan Stanley Analyst forecast on CH:CGN
Erin Wright
Morgan Stanley
Morgan Stanley
CHF300.41
Buy
―
Reiterated
09/29/26
Cigna: Buy Rating Reiterated as Specialty Strength Seen Offsetting PBM Headwinds; Price Target Maintained at $361
Jefferies Analyst forecast on CH:CGN
David Windley
Jefferies
Jefferies
CHF279.61→CHF255.47
Hold
―
Downgraded
08/03/26
Cigna downgraded to Hold from Buy at JefferiesCigna downgraded to Hold from Buy at Jefferies
Raymond James Analyst forecast on CH:CGN
Parker Snure
Raymond James
Raymond James
CHF291.26→CHF266.29
Buy
―
Reiterated
08/03/26
Cigna downgraded to Outperform from Strong Buy at Raymond JamesCigna downgraded to Outperform from Strong Buy at Raymond James
Goldman Sachs Analyst forecast on CH:CGN
Scott Fidel
Goldman Sachs
Goldman Sachs
CHF282.94→CHF292.92
Buy
―
Reiterated
08/02/26
Analysts Conflicted on These Healthcare Names: AbbVie (NYSE: ABBV), HealthStream (NASDAQ: HSTM) and Cigna (NYSE: CI)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
REPLReplimune Group
OVIDOvid Therapeutics
IMUXImmunic
PTGXProtagonist Therapeutics
ESTAEstablishment Labs Holdings
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cigna

3 Months
Ann HynesMizuho Securities
Success Rate
17/28 ratings generated profit
61%
Average Return
+4.32%
Copying Ann Hynes's trades and holding each position for 3 Months would result in 60.71% of your transactions generating a profit, with an average return of +4.32% per trade.
1 Year
Scott FidelGoldman Sachs
Success Rate
21/32 ratings generated profit
66%
Average Return
+15.72%
Copying Scott Fidel's trades and holding each position for 1 Year would result in 65.63% of your transactions generating a profit, with an average return of +15.72% per trade.
2 Years
Scott FidelGoldman Sachs
Success Rate
25/32 ratings generated profit
78%
Average Return
+23.00%
Copying Scott Fidel's trades and holding each position for 2 Years would result in 78.13% of your transactions generating a profit, with an average return of +23.00% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CGN Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
0
0
0
0
0
Buy
25
30
21
24
17
Hold
4
7
5
7
7
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
29
37
26
31
24
In the current month, CGN has received 17 Buy Ratings, 7 Hold Ratings, and 0 Sell Ratings. CGN average Analyst price target in the past 3 months is 282.01.
Each month's total comprises the sum of three months' worth of ratings.

CGN Financial Forecast

CGN Earnings Forecast

Next quarter’s earnings estimate for CGN is CHF6.26 with a range of CHF6.17 to CHF6.49. The previous quarter’s EPS was CHF6.47. CGN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year CGN has Performed in-line its overall industry.
Next quarter’s earnings estimate for CGN is CHF6.26 with a range of CHF6.17 to CHF6.49. The previous quarter’s EPS was CHF6.47. CGN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year CGN has Performed in-line its overall industry.

CGN Sales Forecast

Next quarter’s sales forecast for CGN is CHF60.45B with a range of CHF58.68B to CHF61.82B. The previous quarter’s sales results were CHF59.58B. CGN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year CGN has Performed in-line its overall industry.
Next quarter’s sales forecast for CGN is CHF60.45B with a range of CHF58.68B to CHF61.82B. The previous quarter’s sales results were CHF59.58B. CGN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year CGN has Performed in-line its overall industry.

CGN Stock Forecast FAQ

What is CH:CGN’s average 12-month price target, according to analysts?
Based on analyst ratings, Cigna Corp’s 12-month average price target is 282.01.
    What is CH:CGN’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:CGN, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Cigna Corp a Buy, Sell or Hold?
        Cigna Corp has a consensus rating of Moderate Buy, which is based on 13 buy ratings, 6 hold ratings and 0 sell ratings.
          What is Cigna Corp’s share price target?
          The average share price target for Cigna Corp is 282.01. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is CHF322.05 ,and the lowest forecast is CHF241.33. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Cigna Corp?
            Cigna Corp’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 19 Wall Streets Analysts.
              How can I buy shares of Cigna Corp?
              To buy shares of CH:CGN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.